(Q38910335)

7 September 2017

title

Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles (English)

1 reference

7 September 2017

1 reference

Pelin Çıkla-Süzgün

1

1 reference

7 September 2017

Neerja Kaushik-Basu

2

1 reference

7 September 2017

Amartya Basu

3

1 reference

7 September 2017

Payal Arora

4

1 reference

7 September 2017

Tanaji T Talele

5

1 reference

7 September 2017

Irem Durmaz

6

1 reference

7 September 2017

Rengül Çetin-Atalay

7

1 reference

7 September 2017

Ş Güniz Küçükgüzel

8

1 reference

7 September 2017

publication date

13 February 2015

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

7 September 2017

published in

1 reference

7 September 2017

volume

30

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

778-785

1 reference

COX-2 in cancer--a player that's defining the rules

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Hepatocellular carcinoma: current management and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

An information-intensive approach to the molecular pharmacology of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis of some 3-(arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.971780

10.3109/14756366.2014.971780

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference